Trends of Negotiated Targeted Anticancer Medicines Use in China: An Interrupted Time Series Analysis.
Cong HuangCarolina Oi Lam UngHaishaerjiang WushouerLin BaiXinyi LiXiaodong GuanLu-Wen ShiPublished in: International journal of health policy and management (2021)
The first national negotiation had successfully cut off the price of two negotiated TAMs and promoted TAMs use in China. In the future, government should conduct further price negotiations and include more medicines with clinical benefits into reimbursement schemes to alleviate patients' financial burden and promote their access to essential treatment.